Saturday 17 October 2026
Export SNWV’s income statement to Excel — free account
Sanuwave Health Inc.
SNWV Healthcare Medical Devices
Sanuwave Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.1 million, up 35.0% from fiscal 2024. In the quarter to June 2026, revenue fell 3.13%, EPS fell 224.2%, free cash flow grew 86.8% and total debt fell 28.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
4.96
0.21
−4.06%
Follow SNWV
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 6 | 5 |
+8 more TTM periods Free account |
| (254.57%) | (213.43%) | (166.66%) | 30.70% | ||
| 43.82% | 48.54% | 35.02% | (33.78%) | ||
ROIC |
7.46% | 17.31% | 26.60% | 25.73% | |
Return on Tangible Assets |
209.52% | 218.00% | 134.97% | (192.10%) | |
Average Days of Receivables |
48.10 | 49.39 | 44.93 | 40.97 | |
Free Cash Flow per Share |
1.09 | 1.07 | 0.85 | 0.49 | |
Free Cash Flow |
9.37 | 9.23 | 7.31 | 4.22 | |
Capital Expenditures |
4.15 | 3.44 | 3.43 | 2.92 | |
| Other line items | |||||
Cash ROIC |
29.90% | 27.80% | 20.57% | 14.04% | |
Accounts Receivable Turnover |
9.12 | 8.99 | 10.07 | 11.04 | |
Accounts Payable Turnover |
2.85 | 2.76 | 2.89 | 2.21 | |
Inventory Turnover |
1.61 | 1.82 | 2.00 | 1.75 | |
Average Days of Payables |
115.86 | 117.51 | 117.70 | 162.35 | |
Days of Inventory on Hand |
247.63 | 208.94 | 214.83 | 277.12 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
5.09% | 4.07% | 3.07% | 2.19% | |
Selling, General and Administrative Expense of Revenue |
65.53% | 63.30% | 60.82% | 63.21% | |
Share Based Compensation of Revenue |
13.37% | 12.59% | 11.01% | 12.21% | |
Interest Coverage |
0.43 | 0.66 | 0.79 | 0.53 | |
Operating CF/Net income |
0.34 | 0.35 | 0.33 | (0.13) | |
Depreciation/Fixed assets |
0.84 | 1.21 | 1.39 | 1.68 | |
Capex/Depreciation |
2.20 | 1.49 | 1.25 | 0.87 | |
Revenue per Share |
5.12 | 5.16 | 5.14 | 4.80 | |
Operating CF per Share |
0.61 | 0.67 | 0.45 | 0.15 | |
Capex per Share |
0.48 | 0.40 | 0.40 | 0.34 | |
Capex to Sales |
(0.09) | (0.08) | (0.08) | (0.07) |
Columns are period end dates